Congress Wealth Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-54,029	Closed	-$10.6M	–	879
2024 Q3	$10.6M	Sell	54,029 -529	-1%	-$110K	0.14%	203
2024 Q2	$11.3M	Buy	54,558 +242	+0.4%	+$54.8K	0.18%	160
2024 Q1	$14.7M	Buy	54,316 +500	+0.9%	+$119K	0.25%	115
2023 Q4	$12.7M	Buy	53,816 +302	+0.6%	+$59.4K	0.23%	128
2023 Q3	$10.5M	Buy	53,514 +696	+1%	+$143K	0.22%	135
2023 Q2	$11.1M	Sell	52,818 -512	-1%	-$102K	0.26%	120
2023 Q1	$10.8M	Buy	53,330 +2,358	+5%	+$534K	0.26%	120
2022 Q4	$11.1M	Sell	50,972 -2,121	-4%	-$463K	0.29%	103
2022 Q3	$10.4M	Buy	53,093 +2,172	+4%	+$469K	0.28%	97
2022 Q2	$10.9M	Sell	50,921 -39	-0.1%	-$9.53K	0.28%	96
2022 Q1	$14.5M	Buy	50,960 +726	+1%	+$224K	0.32%	78
2021 Q4	$18.9M	Buy	+50,234	New	+$19.5M	0.38%	66